human papilloma virus

April 27, 2023

Trial combines novel therapies for head and neck cancer

Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.

By Tom Wilemon

January 13, 2022

Study seeks to refine head and neck cancer treatment options

By Bill Snyder